Replies to post #206232 on Avid Bioservices Inc (CDMO)

[md1225]

We longs still win in the end just painful and not right.

Four member board are the only ones that win big.

The drug should be moved ahead for patients the drug should have the potential to be partnered and go to 50-100/share, but I don't believe it will.

Total buyout 15-20/share within a year max imo.